Astellas Pharma Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALPMY Over the counter 2830 www.astellas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Astellas Pharma Inc.

Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4? - Mar 6th, 2026 6:21 am
Pfizer Bladder Cancer Trial Results Deepen Oncology Growth And Risk Debate - Mar 5th, 2026 10:10 am
Pfizer Inc. (PFE) and Astellas Report Positive Phase 3 EV-304 Results for PADCEV Plus Keytruda in Bladder Cancer - Mar 3rd, 2026 10:48 pm
Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM - Mar 1st, 2026 2:27 am
Vir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus - Feb 28th, 2026 4:12 am
Merck Says Keytruda Plus Padcev Decreases Risk of Death in Bladder Cancer Trial - Feb 27th, 2026 9:39 am
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer - Feb 27th, 2026 8:00 am
Melodia Therapeutics Announces U.S. Patent Grant Covering MLD-151 - Feb 25th, 2026 6:00 am
Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas - Feb 24th, 2026 2:09 pm
Vir climbs on Astellas deal, study results for ‘masked’ T cell engager - Feb 24th, 2026 5:18 am
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - Feb 23rd, 2026 3:00 pm
Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development - Feb 18th, 2026 8:10 am
India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - Feb 12th, 2026 11:50 am
Is It Too Late To Consider Astellas Pharma (TSE:4503) After An 83% One-Year Rally? - Feb 12th, 2026 12:09 am
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight - Feb 10th, 2026 3:31 pm
India's Lupin settles US patent dispute with Astellas Pharma for $90 million - Feb 9th, 2026 10:32 pm
Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption? - Feb 5th, 2026 6:48 am
Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock? - Jan 22nd, 2026 4:15 am
Has Astellas Pharma (TSE:4503) Run Too Far After Its 61% One Year Share Price Jump? - Jan 15th, 2026 10:09 pm
Ocular Launches, And Then Yo-Yoes, On Rumors Sanofi Is Preparing A Bigger Bid - Jan 15th, 2026 2:20 pm